Royalty Pharma is headquartered in New York City and opened its first Asia-Pacific base in Hong Kong, while Kenneth Sun moved from Morgan Stanley to the company.
1 report, 1 independent
Updated Jun 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royalty Pharma is headquartered in New York City and opened its first Asia-Pacific base in Hong Kong, while Kenneth Sun moved from Morgan Stanley to the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Royalty Pharma
biopharmaceutical company based in New York City
-
New York City
most populous city in the United States
-
Hong Kong
city and special administrative region of China
Related events
- Ascletis Pharma Inc. is based in Hong Kong.
- Royalty Pharma outperformed the market so far this year, based on data from August 6, 2025.
- Pablo Legorreta was named the founder and CEO of Royalty Pharma, which provides funding in exchange for royalty rights.
- Raytech Holding Limited, a company based in Hong Kong, has its stock trading on the Nasdaq exchange.
- Techtronic Industries established its headquarters in Hong Kong.